NEW YORK– DLA Piper advised Arlington Capital Partners and Everest Clinical Research (Everest), a leading full-service contract research organization (CRO) with expertise in biostatistics and statistical programming, in its acquisition of Brightech International (Brightech), a leading CRO that specializes in complex, value-add biostatistics, programming and clinical data management services.
The acquisition of Brightech will help Everest expand its capabilities and global footprint, deepen its R&D resources, and accelerate its growth. Brightech will continue to be led by its existing management team.
“The acquisition of Brightech will provide Everest with the opportunity to expand its world class capabilities and its geographic reach,” said Jeffrey Houle, co-chair of DLA Piper’s Aerospace, Defense and Government Services Transactional Practice, who led the deal team. “It was a pleasure working with Arlington Capital Partners and Everest to combine these two highly respected teams at the forefront of innovation in the industry.”
Along with Houle (Washington, DC), the DLA Piper team that advised Arlington Capital Partners and Everest included partners Julia Kovacs, Richard Newcomb, and Jennifer Kashatus (Washington, DC), Thomas Pilkerton III and Jordan Bailowitz (Baltimore), Christopher Mikson, MD (Philadelphia), Sarah Tauman (San Francisco), Nate McKitterick (Palo Alto), Russel Drew and Kevin Fritz (Toronto), Qiang Li (Shanghai), J Carolyn Bigg and Johnny Choi (Hong Kong) and Amanda Ge (Beijing); and associates Josh Feldman (Baltimore), Xu Zhou (Shanghai) and Venus Cheung (Hong Kong).
With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 12 consecutive years, according to Mergermarket.
With more than 125 US lawyers who provide strategic counsel to private equity funds and their industry-leading portfolio companies, DLA Piper’s Private Equity practice has the capacity, experience and relationships to help drive value across the investment life cycle by delivering responsive, efficient and integrated solutions around the world.
